Literature DB >> 10550668

Immunological characterization of Toscana virus proteins.

P Di Bonito1, L Nicoletti, S Mochi, L Accardi, A Marchi, C Giorgi.   

Abstract

The genome of Toscana virus (Bunyaviridae family, Phlebovirus genus) consists of three single stranded RNA segments (L, M, S), with negative polarity. The L and M segments contain a single ORF in viral complementary sense and the S segment contains two ORFs in "ambisense" orientation. The M segment codes for three proteins in 3'-5' genomic orientation: a 30 kDa non structural protein and two 65 kDa glycoproteins, GN, and GC. In this paper we report the expression in E. coli of the S segment ORFs and of three regions of the L ORF. The expressed proteins were used to produce monospecific polyclonal antibodies in mice. By using these antibodies the N and the NSs proteins were unequivocally assigned to the S viral-complementary and viral-sense ORFs, respectively, and the L protein to the L ORF. We have found that like N and L proteins, NSs protein is associated with the viral nucleocapsids in mature virions, suggesting its possible involvement in early events of viral replication. NSs protein was also found associated with cellular polysomes. In virus-infected cells the anti-L antibodies recognized proteins shorter than the full-length L protein, possibly products of L subgenomic segments. Interestingly these defective products were not found in mature virions, suggesting specific mechanisms in virion assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550668     DOI: 10.1007/s007050050717

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

Review 1.  A Mediterranean arbovirus: the Toscana virus.

Authors:  Marcello Valassina; Maria Grazia Cusi; Pier Egisto Valensin
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

2.  Analysis of the Tomato spotted wilt virus ambisense S RNA-encoded hairpin structure in translation.

Authors:  Christina Geerts-Dimitriadou; Yun-Yueh Lu; Corinne Geertsema; Rob Goldbach; Richard Kormelink
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

3.  Seroprevalence of Toscana virus in blood donors, France, 2007.

Authors:  Nadège Brisbarre; Houssam Attoui; Pierre Gallian; Paola Di Bonito; Colomba Giorgi; Jean-Francois Cantaloube; Philippe Biagini; Mhammed Touinssi; Francois Jordier; Philippe de Micco
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

4.  Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.

Authors:  Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen; Colomba Giorgi
Journal:  Infect Agent Cancer       Date:  2006-11-08       Impact factor: 2.965

5.  Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS.

Authors:  Alessandra Carattoli; Paola Di Bonito; Felicia Grasso; Colomba Giorgi; Francesco Blasi; Matthias Niedrig; Antonio Cassone
Journal:  J Med Virol       Date:  2005-06       Impact factor: 2.327

6.  Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins.

Authors:  Xiaohong Shi; Richard M Elliott
Journal:  J Gen Virol       Date:  2009-02       Impact factor: 3.891

7.  Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.

Authors:  Elena Illiano; Olivia Costantina Demurtas; Silvia Massa; Paola Di Bonito; Valerio Consalvi; Roberta Chiaraluce; Carlo Zanotto; Carlo De Giuli Morghen; Antonia Radaelli; Aldo Venuti; Rosella Franconi
Journal:  J Transl Med       Date:  2016-07-28       Impact factor: 5.531

Review 8.  Phleboviruses and the Type I Interferon Response.

Authors:  Jennifer Deborah Wuerth; Friedemann Weber
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.